A safety study of PF-08046045/SGN-35T in adults with advanced cancers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502390-41-00

Acronym

C5811001/ SGN35T-001

Enrollment

Registered

2024-04-29

Start date

2024-06-20

Completion date

2025-07-15

Last updated

2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaplastic Large-Cell Lymphoma T- and Null-Cell Types, Angioimmunoblastic T-Cell Lymphoma, B-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, Peripheral T-Cell Lymphoma unspecified, Primary Mediastinal large B-Cell Lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Denmark, Germany, Italy, Spain

Outcome results